MedTrace Logo

Ramipril in Pediatric Patients on Hemodialysis

NCT04582097 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2020-10-14

No results posted yet for this study

Summary

The aim of the study is to evaluate the effect of Ramipril in pediatric patients on regular hemodilaysis

Conditions

  • Hemodialysis

Interventions

DRUG

Ramipril

angiotensin-converting enzyme inhibitor

DRUG

placebo

same odor, color and size as the drug but without the active ingredient

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Ain Sh University · university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-03-01
Completion
2020-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04582097 on ClinicalTrials.gov